[Differential therapy of infectious diarrhea]

H Grundmann1

  • 1Institut für Umweltmedizin und Krankenhaushygiene, Universitätsklinik, Freiburg.

Praxis
|October 18, 1994
PubMed

Insights

Diarrheal diseases are a major global health threat, especially in children. Pathogens like Salmonella and Campylobacter spread through food production, requiring awareness of emerging infectious diarrhea risks.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Public Health

Context:

  • Diarrheal diseases are a leading cause of morbidity and mortality worldwide, particularly impacting young children.
  • While industrialized nations are less affected by classical waterborne epidemics, infectious diarrhea remains prevalent.
  • Factors like industrial food production, global travel, and migration contribute to the spread of enteric pathogens.

Purpose:

  • To highlight the significant burden of diarrheal diseases globally.
  • To identify key causative agents, including toxigenic enterobacteria, non-typhoidal Salmonella, Campylobacter, and viruses.
  • To underscore the evolving landscape of infectious diarrhea, including emerging pathogens and risk factors.

Summary:

  • Communicable diarrheal diseases are a primary cause of illness and death globally, with young children being especially vulnerable.
  • Recurrent diarrheal episodes in children are frequently linked to specific pathogens such as toxigenic enterobacteria, non-typhoidal Salmonella, and Campylobacter.
  • Industrialized food production systems and changing societal patterns increase the risk of pathogen transmission, necessitating vigilance against both common and rare infectious agents.

Impact:

  • Emphasizes the persistent threat of diarrheal diseases, especially in vulnerable populations.
  • Informs public health strategies for controlling infectious diarrhea through pathogen surveillance and food safety measures.
  • Raises awareness among healthcare professionals and policymakers about the dynamic nature of infectious diarrhea and the need for preparedness.

Related Concept Videos

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Differential Staining Technique01:26

Differential Staining Technique

Differential staining is an essential microbiological technique that exploits variations in cell wall structures to classify and identify microorganisms. It facilitates the distinction of bacteria, aiding in diagnostic and research applications. Two of the most widely used differential staining methods are Gram staining and acid-fast staining, both of which rely on the chemical and structural differences in bacterial cell walls.Gram Staining TechniqueGram staining differentiates bacteria by...